The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013-Reference-Cited by-同舟云学术

The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013

Published:2021-11-08 Issue: Volume: Page:
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Cabrera Sofia Ferrer¹,Muratore Michael E.¹^ORCID,Buijnsters Peter¹

Affiliation:

1. A Division of Janssen Pharmaceutica NV, Discovery Chemistry department, Discovery, Product Development & Supply, Janssen Research and Development, Beerse, Belgium

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2022.2003780

Reference123 articles.

1. 1Jones DP, Lash LH. Introduction: Criteria for assessing normal and abnormal mitochiondrial function in mitochondrial disease genes compendium: From genes to clinical manifestations; Marni JF (ed.); Academic press Elsevier 2020; 1-7.

2. 2Nakamura N, Hirose S. Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. Mol. Biol. Cell 2008; 19; 1903-1911.

3. 3Nunnari J, Suomalainen A. Mitochondria: In Sickness and in Health. Cell 2012; 148; 1145-1159.

4. 4Labbé K, Murley A, Nunnari J. Determinants and functions of mitochondria behavior. Annu. Rev. Cell Dev. Biol. 2014; 30; 357-391.

5. 5Liang JR, Martinez A, Lane JD, et al. USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. EMBO Rep. 2015; 16; 618-627.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP30 impairs mitochondrial quality control and aggravates oxidative damage after traumatic brain injury;Biochemical and Biophysical Research Communications;2023-09

2. DEUBIQUITINASES AND THEIR INHIBITORS: CHALLENGES AND RECENT ADVANCES;2022 Medicinal Chemistry Reviews;2022-12-21

3. USP30: Structure, Emerging Physiological Role, and Target Inhibition;Frontiers in Pharmacology;2022-03-03